News
Hosted on MSN30m
Ultragenyx’s GTX-102 Receives FDA Breakthrough Therapy Designation for Angelman SyndromeUltragenyx Pharmaceutical Inc. (NASDAQ:RARE) is one of the most promising stocks according to Wall Street analysts. On June ...
Super Micro Computer Inc. (NASDAQ: SMCI) plans to significantly expand its AI server manufacturing operations in Europe, ...
Wolfspeed shares opened with a 43% jump on Tuesday over the previous day’s close of $1.18 and reached an intraday high of ...
Track Indian market opening as GIFT Nifty signals a weak start amid global cues and Trump’s tariff threats - find out today's ...
Government officials say adversaries’ U.S. farmland ownership can imperil national security, while China has dismissed the ...
Nasdaq shows technical momentum, yet valuation concerns persist. Analysts expect steady EPS growth, but fair value is in the ...
Nvidia (NASDAQ: NVDA) shares climbed 1.1% to close at $160 today, bucking the cautious sentiment that weighed on major indices. The technology-heavy Nasdaq Composite gained just 0.03% and ...
Equities in Toronto ran out of steam Tuesday, amid uncertainty over U.S. President Trump's timing and severity of tariffs ...
ReserveOne, a new cryptocurrency holding company with ties to industry veterans and a former U.S. commerce secretary, said on ...
The U.S. Supreme Court on Tuesday allowed the Trump administration to move forward with plans to downsize the federal ...
With Bitcoin still gaining momentum, the Trump Media and Technology Group (NASDAQ: DJT) just filed with the US SEC to bring the Truth Social Crypto Blue-Chip ETF to market. Reportedly, the ETF will ...
Tuesday's relatively muted action in markets follows losses on Monday when Trump posted a flurry of letters to social media ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results